UC Irvine Researchers Identify Dopamine Dysfunction as Key Factor in Alzheimer's Memory Loss
Researchers at the University of California, Irvine have discovered that dopamine dysfunction in the entorhinal cortex, a critical brain region for memory, plays a significant role in memory impairment associated with Alzheimer's disease. The study, published in Nature Neuroscience, reveals that dopamine levels in this area are reduced by over 80%, hindering neurons' ability to form associative memories. The research team, led by Kei Igarashi, demonstrated that memory function could be restored in mice using Levodopa, a drug commonly used for Parkinson's disease. This approach contrasts with current treatments that focus on clearing protein plaques, suggesting a new therapeutic strategy that targets neuronal circuits. The findings open the possibility of repurposing Levodopa for clinical trials to address early memory loss in Alzheimer's patients. 
